MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its investment in Wilson Wolf Manufacturing. Wilson Wolf achieved the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne’s initial investment in the company. Bio-Techne’s $257 million investment gives the Company a 20% ownership stake in Wilson […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission’s (“FTC”) decision ordering the unwinding of Illumina’s acquisition of GRAIL. Illumina intends to file a petition for review promptly with a US Court of Appeals and will seek expedited treatment of the appeal. The FTC’s order to unwind the […]
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to […]
France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to […]
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announces its participation in a cohort study led by the UK National Institute for Health and Care Research (NIHR) BioResource to further explore human health and disease. The study would involve using Oxford Nanopore’s platform to sequence up to 22,000 […]
Strategic investment is closely linked to ZEISS Research Microscopy Solutions and its capabilities in automated, high-resolution imaging and 3D image analysis Oberkochen, Germany | ZEISS Group ZEISS is investing in life science start-up InSphero to further advance the adoption of 3D microtissues in research and drug development. InSphero AG, a pioneer in 3D spheroid and […]
TATAA Biocenter, a leading provider of high-quality molecular analysis services, announced today that it has become a certified Qualified Service Provider for HTG Molecular Diagnostics. This certification will enable TATAA to offer high-throughput, multiplex gene expression profiling to its customers, and expand its portfolio of molecular analysis services. HTG Molecular Diagnostics is a life science […]
HUNTSVILLE, Ala. —Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeqTM X Plus Sequencing Systems from Illumina, Inc. Discovery Genomics will expand its platform to five systems by the end of the year―positioning itself as […]
SAN DIEGO — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders. The activist investor Carl Icahn has nominated three of his associates to stand for election to the Board of Directors at Illumina’s 2023 […]
BOSTON — Stilla Technologies and Atila BioSystems today announced an agreement to market digital PCR kits and assays produced by Atila BioSystems for use on the naica® system (Stilla Technologies). The digital PCR kits, optimized specifically for use with the 6-color naica® system, will be utilized for the detection of circulating tumor DNA (ctDNA) from liquid biopsy samples taken […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
